title: Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.
abstract: BACKGROUND
  The diagnosis of Marfan syndrome (MFS) is usually initially based on clinical criteria according to the number of major and minor systems affected following international nosology. The number of FBN1 mutation carriers, at risk of aortic complications who would not be properly diagnosed based only on clinical grounds, is of growing importance owing to the increased availability of molecular screening. The aim of the study was to identify patients who should be considered for FBN1 mutation screening.
  
  
  METHODS
  Our international series included 1009 probands with a known FBN1 mutation. Patients were classified as either fulfilling or not fulfilling "clinical" criteria. In patients with unfulfilled "clinical" criteria, we evaluated the percentage of additional patients who became positive for international criteria when the FBN1 mutation was considered. The aortic risk was evaluated and compared in patients fulfilling or not fulfilling the "clinical" international criteria.
  
  
  RESULTS
  Diagnosis of MFS was possible on clinical grounds in 79% of the adults, whereas 90% fulfilled the international criteria when including the FBN1 mutation. Corresponding figures for children were 56% and 85%, respectively. Aortic dilatation occurred later in adults with unfulfilled "clinical criteria" when compared to the Marfan syndrome group (44% vs 73% at 40 years, p<0.001), but the lifelong risk for ascending aortic dissection or surgery was not significantly different in both groups.
  
  
  CONCLUSIONS
  Because of its implications for aortic follow-up, FBN1 molecular analysis is recommended in newly suspected MFS when two systems are involved with at least one major system affected. This is of utmost importance in patients without aortic dilatation and in children.
authors.forename: L
authors.initials: L
authors.lastname: Faivre
authors.forename: G
authors.initials: G
authors.lastname: Collod-Beroud
authors.forename: A
authors.initials: A
authors.lastname: Child
authors.forename: B
authors.initials: B
authors.lastname: Callewaert
authors.forename: B L
authors.initials: BL
authors.lastname: Loeys
authors.forename: C
authors.initials: C
authors.lastname: Binquet
authors.forename: E
authors.initials: E
authors.lastname: Gautier
authors.forename: E
authors.initials: E
authors.lastname: Arbustini
authors.forename: K
authors.initials: K
authors.lastname: Mayer
authors.forename: M
authors.initials: M
authors.lastname: Arslan-Kirchner
authors.forename: C
authors.initials: C
authors.lastname: Stheneur
authors.forename: A
authors.initials: A
authors.lastname: Kiotsekoglou
authors.forename: P
authors.initials: P
authors.lastname: Comeglio
authors.forename: N
authors.initials: N
authors.lastname: Marziliano
authors.forename: D
authors.initials: D
authors.lastname: Halliday
authors.forename: C
authors.initials: C
authors.lastname: Beroud
authors.forename: C
authors.initials: C
authors.lastname: Bonithon-Kopp
authors.forename: M
authors.initials: M
authors.lastname: Claustres
authors.forename: H
authors.initials: H
authors.lastname: Plauchu
authors.forename: P N
authors.initials: PN
authors.lastname: Robinson
authors.forename: L
authors.initials: L
authors.lastname: Adès
authors.forename: J
authors.initials: J
authors.lastname: De Backer
authors.forename: P
authors.initials: P
authors.lastname: Coucke
authors.forename: U
authors.initials: U
authors.lastname: Francke
authors.forename: A
authors.initials: A
authors.lastname: De Paepe
authors.forename: C
authors.initials: C
authors.lastname: Boileau
authors.forename: G
authors.initials: G
authors.lastname: Jondeau
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001011:Aorta / Q000473:pathology; D002648:Child; D005260:Female; D000071838:Fibrillin-1; D000071837:Fibrillins; D006801:Humans; D007391:International Cooperation; D008297:Male; D008382:Marfan Syndrome / Q000175:diagnosis* / Q000235:genetics*; D008840:Microfilament Proteins / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D054392:Adipokines
chemical_list: D000071838:Fibrillin-1; D000071837:Fibrillins; D008840:Microfilament Proteins; C000605722:FBN1 protein, human; D054392:Adipokines